228 related articles for article (PubMed ID: 19809881)
1. Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma.
Kilfoy BA; Zheng T; Lan Q; Han X; Holford T; Hein DW; Qin Q; Leaderer B; Morton LM; Yeager M; Boyle P; Zhao P; Chanock S; Rothman N; Zhang Y
Cancer Causes Control; 2010 Jan; 21(1):127-33. PubMed ID: 19809881
[TBL] [Abstract][Full Text] [Related]
2. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
Gibson TM; Smedby KE; Skibola CF; Hein DW; Slager SL; de Sanjosé S; Vajdic CM; Zhang Y; Chiu BC; Wang SS; Hjalgrim H; Nieters A; Bracci PM; Kricker A; Zheng T; Kolar C; Cerhan JR; Darabi H; Becker N; Conde L; Holford TR; Weisenburger DD; De Roos AJ; Butterbach K; Riby J; Cozen W; Benavente Y; Palmers C; Holly EA; Sampson JN; Rothman N; Armstrong BK; Morton LM
Cancer Causes Control; 2013 Jan; 24(1):125-34. PubMed ID: 23160945
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS
Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422
[TBL] [Abstract][Full Text] [Related]
4. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB
Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843
[TBL] [Abstract][Full Text] [Related]
5. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
6. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
Gu J; Liang D; Wang Y; Lu C; Wu X
Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
[TBL] [Abstract][Full Text] [Related]
8. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
[TBL] [Abstract][Full Text] [Related]
9. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.
Morton LM; Bernstein L; Wang SS; Hein DW; Rothman N; Colt JS; Davis S; Cerhan JR; Severson RK; Welch R; Hartge P; Zahm SH
Carcinogenesis; 2007 Aug; 28(8):1759-64. PubMed ID: 17522066
[TBL] [Abstract][Full Text] [Related]
10. NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.
Matejcic M; Vogelsang M; Wang Y; Iqbal Parker M
BMC Cancer; 2015 Mar; 15():150. PubMed ID: 25886288
[TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.
Cocco P; Zucca M; Sanna S; Satta G; Nonne T; Angelucci E; Gabbas A; Rais M; Malpeli G; Campagna M; Scarpa A; G Ennas M
Hematol Oncol; 2016 Jun; 34(2):79-83. PubMed ID: 25689677
[TBL] [Abstract][Full Text] [Related]
12. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people.
Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA
Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162
[TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.
Majumder M; Ghosh S; Roy B
Indian J Med Res; 2012 Oct; 136(4):605-13. PubMed ID: 23168701
[TBL] [Abstract][Full Text] [Related]
14. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
[TBL] [Abstract][Full Text] [Related]
15. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk.
Henning S; Cascorbi I; Münchow B; Jahnke V; Roots I
Pharmacogenetics; 1999 Feb; 9(1):103-11. PubMed ID: 10208649
[TBL] [Abstract][Full Text] [Related]
16. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
[TBL] [Abstract][Full Text] [Related]
17. Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis.
Sanderson S; Salanti G; Higgins J
Am J Epidemiol; 2007 Oct; 166(7):741-51. PubMed ID: 17675654
[TBL] [Abstract][Full Text] [Related]
18. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.
Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y
Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
20. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
